Drug Type Small molecule drug |
Synonyms ICP 105 |
Target |
Action antagonists |
Mechanism FGFR4 antagonists(Fibroblast growth factor receptor 4 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 21 Sep 2018 | |
| Solid tumor | Phase 1 | China | 31 Aug 2018 | |
| Solid tumor | Phase 1 | China | 31 Aug 2018 | |
| Liver Cancer | IND Application | China | 03 Jan 2018 | |
| Liver Cancer | IND Application | China | 03 Jan 2018 |





